179 related articles for article (PubMed ID: 16457647)
1. Gene therapy of cancer based on interleukin 12.
Sangro B; Melero I; Qian C; Prieto J
Curr Gene Ther; 2005 Dec; 5(6):573-81. PubMed ID: 16457647
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.
Hernandez-Alcoceba R; Poutou J; Ballesteros-Briones MC; Smerdou C
Immunotherapy; 2016 Feb; 8(2):179-98. PubMed ID: 26786809
[TBL] [Abstract][Full Text] [Related]
3. Advances in interleukin-12 gene therapy for acquired liver diseases.
Berraondo P; Prieto J; Gonzalez-Aseguinolaza G
Curr Gene Ther; 2009 Apr; 9(2):62-71. PubMed ID: 19355864
[TBL] [Abstract][Full Text] [Related]
4. Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12.
Waehler R; Ittrich H; Mueller L; Krupski G; Ameis D; Schnieders F
Hum Gene Ther; 2005 Mar; 16(3):307-17. PubMed ID: 15812226
[TBL] [Abstract][Full Text] [Related]
5. A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma.
Gao JQ; Sugita T; Kanagawa N; Iida K; Eto Y; Motomura Y; Mizuguchi H; Tsutsumi Y; Hayakawa T; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2005 Mar; 328(4):1043-50. PubMed ID: 15707983
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor.
Jin HT; Youn JI; Kim HJ; Lee JB; Ha SJ; Koh JS; Sung YC
Hum Gene Ther; 2005 Mar; 16(3):328-38. PubMed ID: 15812228
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy of cancer with interleukin-12.
Mazzolini G; Prieto J; Melero I
Curr Pharm Des; 2003; 9(24):1981-91. PubMed ID: 12871184
[TBL] [Abstract][Full Text] [Related]
8. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.
Rodriguez-Madoz JR; Zabala M; Alfaro M; Prieto J; Kramer MG; Smerdou C
Hum Gene Ther; 2014 Feb; 25(2):132-43. PubMed ID: 24219025
[TBL] [Abstract][Full Text] [Related]
9. Cytokine gene transfer into dendritic cells for cancer treatment.
Tirapu I; Rodriguez-Calvillo M; Qian C; Duarte M; Smerdou C; Palencia B; Mazzolini G; Prieto J; Melero I
Curr Gene Ther; 2002 Feb; 2(1):79-89. PubMed ID: 12108975
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.
Kang WK; Park C; Yoon HL; Kim WS; Yoon SS; Lee MH; Park K; Kim K; Jeong HS; Kim JA; Nam SJ; Yang JH; Son YI; Baek CH; Han J; Ree HJ; Lee ES; Kim SH; Kim DW; Ahn YC; Huh SJ; Choe YH; Lee JH; Park MH; Kong GS; Park EY; Kang YK; Bang YJ; Paik NS; Lee SN; Kim SH; Kim S; Robbins PD; Tahara H; Lotze MT; Park CH
Hum Gene Ther; 2001 Apr; 12(6):671-84. PubMed ID: 11426466
[TBL] [Abstract][Full Text] [Related]
11. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.
Govaerts AS; Guillaume T; André M; Bayat B; Feyens AM; Hawley TS; Fong AZ; Hawley RG; Symann M
Cancer Gene Ther; 1999; 6(5):447-55. PubMed ID: 10505855
[TBL] [Abstract][Full Text] [Related]
12. Tailor-made fibroblast-specific and antibiotic-free interleukin 12 plasmid for gene electrotransfer-mediated cancer immunotherapy.
Kamensek U; Tesic N; Sersa G; Kos S; Cemazar M
Plasmid; 2017 Jan; 89():9-15. PubMed ID: 27890562
[TBL] [Abstract][Full Text] [Related]
13. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
Kanagawa N; Gao JQ; Motomura Y; Yanagawa T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
Biochem Biophys Res Commun; 2008 Aug; 372(4):821-5. PubMed ID: 18519033
[TBL] [Abstract][Full Text] [Related]
14. Gene-based strategies for the immunotherapy of cancer.
Tüting T; Storkus WJ; Lotze MT
J Mol Med (Berl); 1997 Jul; 75(7):478-91. PubMed ID: 9253711
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy of hepatocellular carcinoma and gastrointestinal tumors.
Sangro B; Qian C; Schmitz V; Prieto J
Ann N Y Acad Sci; 2002 Jun; 963():6-12. PubMed ID: 12095923
[TBL] [Abstract][Full Text] [Related]
16. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells.
Kim TH; Jin H; Kim HW; Cho MH; Cho CS
Mol Cancer Ther; 2006 Jul; 5(7):1723-32. PubMed ID: 16891458
[TBL] [Abstract][Full Text] [Related]
17. Localized Interleukin-12 for Cancer Immunotherapy.
Nguyen KG; Vrabel MR; Mantooth SM; Hopkins JJ; Wagner ES; Gabaldon TA; Zaharoff DA
Front Immunol; 2020; 11():575597. PubMed ID: 33178203
[TBL] [Abstract][Full Text] [Related]
18. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
19. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
20. Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12.
Caminschi I; Venetsanakos E; Leong CC; Garlepp MJ; Robinson BW; Scott B
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):347-56. PubMed ID: 10460752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]